Agoracom Blog Home

Posts Tagged ‘CSE’

VIDEO – Empower Clinics $CBDT.ca Grows Revenue 416% To $USD 790,000 In Q1 – BEFORE COVID-19 Revenues Commenced In Q2 $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 5:36 PM on Wednesday, July 29th, 2020

Sometimes, you just have to let the numbers speak for themselves.  With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for …

but then these numbers came in for:   2019 – Year Ended DEC 31, 2019 Q4 – Quarter Ended DEC 31, 2019 Q1 – Quarter Ended MAR 31, 2020  

Patient Visits

  • 2019 +110% To 15,900
  • Q4 + 251% To 4,616
  • Q1 + 377% To 5,717 (PRE COVID REVENUES COMMENCING Q2)

Revenues $USD

  • 2019 + 86% To $2.03M
  • Q4 + 217% To $625,000
  • Q1 + 416% To $790,000  (PRE COVID REVENUES COMMENCING Q2)  

Do you see a trend?   

We can’t wait for Q2 numbers (April, May, June) because we already know patient visits for April alone were up over 870%.   

Looking even further forward into Q3 (July, August, September), we already know that July patient visits are going to set a record.    

Though CBDT had a very short cease trade order due to the delay in getting these financials filed…. the wait was clearly worth it, as was this interview with CEO, Steven McAuley,  who is Six Sigma certified under the quality initiative of legendary GE (General Electric) Chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history and turn it into significant growth.  

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

VIDEO – New Age Metals $NAM.ca 2.9M Ounces Of Palladium Equivalent Is Why Eric Sprott Owns 18.5% $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 5:14 PM on Wednesday, July 29th, 2020

Three years ago, Harry Barr couldn’t get anyone to even look at New Age Metals (NAM:TSXV) flagship property, the 100% owned River Valley Project, one of North America’s largest undeveloped Platinum Group Metals Projects, situated 100 kilometres from Sudbury.  

But with Palladium at $US 2,100/oz and River Valley sitting on 2.9Moz Palladium Equivalent (Measured & Indicated), things have changed significantly, including the fact that  Eric Sprott has become a strategic shareholder with 18.56% ownership.  

WAIT … THERE’S MORE  

NAM’s 2019 Preliminary Economic Assessment highlights include a 14 year mine life, resulting in an annual average payable Palladium Equivalent production of 119,000 ounces.  

WAIT ….. THERE’S ONE MORE THING  

The PEA assumed a Palladium price of $US 1,200, which is now 75% higher at $US 2,100.   With NAM now using their war chest to further drill River Valley and follow-up on recommendations from the PEA, there is reason to believe this story is only going to get better.  

Grab your favourite beverage and watch this interview with NAM CEO, Harry Barr.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

Spyder Cannabis $SPDR.ca Announces Final Approvals to Open Niagara Falls and Calgary Cannabis Dispensaries $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 8:40 AM on Wednesday, July 29th, 2020
  • Announced that its dispensary located at 6474 Lundy’s Lane, passed its final inspection on July 27, 2020, and intends to open for business in the first week of August 2020
  • Also announced that its dispensary located at #140, 104 – 58 Avenue SE, was formally issued a Retail Cannabis Store License (No. 781144-1) and intends to open for business in August 2020

Vaughan, Ontario–(July 29, 2020) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“) and its wholly-owned associated applicants, The Green Spyder Inc. and Spyder Cannabis Subco Inc., is pleased to provide the following update:

Niagara Falls and Cannabis Dispensary

The Company is pleased to announce that its dispensary located at 6474 Lundy’s Lane, passed its final inspection on July 27, 2020, and intends to open for business in the first week of August 2020.

Calgary Cannabis Dispensary

The Company is also pleased to announce that its dispensary located at #140, 104 – 58 Avenue SE, was formally issued a Retail Cannabis Store License (No. 781144-1) and intends to open for business in August 2020.

“Both dispensaries are located in busy commercial hubs, in their respective cities. The Spyder team is excited to commence operations and bring its best of class customer service and retail experience to both cities”, stated Dan Pelchovitz, the Company’s CEO.

About Spyder Cannabis Inc.

Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of Hemp CBD in the United States only, the third is the sale of smoking cessation products in Ontario.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain ‘forward-looking information” within the meaning of applicable securities laws (‘forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

For additional info, please contact:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Telephone: 1.888.504.7737
Email: [email protected]

VIDEO: Else Nutrition $BABY.ca Begins Selling Plant-Based Products For US Toddlers Market $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 4:18 PM on Tuesday, July 28th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

When the subsidiary of a Billion Dollar, Nutrition Focused company buys 11.5% of your stock, agrees to a voluntary 12-month lock up and holds anti-dilution rights to maintain it’s ownership percentage by buying a proportionate number of shares in any future financing, it is safe to assume you have a strategic investor who believes in the future of your company.

When that same strategic investor wants to then help your company expand into large international markets, it is safe to assume your plant based food capabilities are amongst the most respected in the world.

This is just a glimpse into the strength of Else Nutrition (BABY:TSXV) (BABYF:OTCQB), an Israeli based, award winning plant based food nutrition company that is giving small cap investors an opportunity to participate in the global paradigm shift towards plant-based, clean label foods.US MARKET COMMERCIALIZATION COMMENCES

Given what you now know, it should come as no surprise that – as part of its path to commercialization in the U.S.A. – it has just successfully completed its first full-scale commercial production run of its Plant-based Toddler Nutrition product. The production run was completed at the U.S. based facilities of the Company’s production partner, a leading producer of organic baby formula in the U.S.   BABY CEO Hamutal Yitzhak stated “These accomplishments further demonstrate our readiness for launch into the North American marketplace.Parents across North America have been looking for clean, plant-based, whole food nutrition options for their children – and we are set to make this a reality” “Making it a reality”appears imminent because the company has signed broker agreements with three (3) reputable, natural food retail brokers, and is close to signing with a fourth broker.  Moreover, pre-orders are already commencing online.  In short, BABY is on the proverbial commercial launch pad into a paradigm shifting industry that itself is also on the launch pad for the 2020 decade – Plant Based, Clean Label Foods.   

If you believe in the future of plant-based, clean label foods or want to discover its possibilities, then watch this incredible interview with CEO Hamutal Yitzhak.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

Datametrex $DM.ca Appoints Hon. James S. Peterson, P.C.

Posted by AGORACOM-JC at 11:01 AM on Tuesday, July 28th, 2020
  • Announced the appointment of Hon. James S. Peterson, P.C., as a new independent member of the Board of Directors
  • Hon. Peterson is a former federal Cabinet Minister and Secretary of State, with extensive knowledge and first-hand experience legal, financial, board governance and government affairs

TORONTO, July 28, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce the appointment of Hon. James S. Peterson, P.C., as a new independent member of the Board of Directors. Hon. Peterson is a former federal Cabinet Minister and Secretary of State, with extensive knowledge and first-hand experience legal, financial, board governance and government affairs.

“I want to thank our newest Board Member for taking on the position of Director at Datametrex,” said CEO, Marshall Gunter. “His diplomacy and global business acumen are critical assets to better position us in the market, so that we can operate at the highest level in this changing environment. We continue striving for increased collaboration with new consortia in the preventive technologies industries around the world.”

Jim Peterson with his government experience on the world stage brings a wealth of knowledge in strategic planning and government affairs. He will be using this experience in helping Datametrex engage with world governments to bring more testing to the general population to eradicate the spread of the COVID-19 virus. 

Jim obtained his BA and LLB from Western University, his LLM from Columbia University and his DCL from McGill University. He also taught Law at University of Toronto, and worked for the UN International development organization in Vienna, Khartoum, and Kuala Lumpur on International joint business ventures in developing countries. He is a Member of the Ontario Bar Association, the Canadian Bar Association, and is a Co-Chair of the Canada-US Law Institute. Jim has also served for the Government of Canada as Minister of International Trade, Secretary of State (International Financial Institutions), and Chair of the House of Commons Standing Committee on Finance. While a Cabinet Minister, Jim represented Canada at the World Trade Organization’s Doha round of negotiations, which were focused on expanding trade and investment in leading emerging markets Brazil, Russia, India and China, and with complex issues related to trade with Canada’s NAFTA partners, the European Union, the Middle East and the Americas.

Jim served as Chair of the House of Commons Finance Committee where he began the practice of public pre-budget hearings and completed several major studies including a review of Canada’s value added tax (the GST). He retired from the House of Commons in 2007 after 23 years of public service as the Member of Parliament for Willowdale (Toronto).

“I am a firm believer that time is a resource that companies in high-growth mode cannot afford to waste,” Hon. Peterson said. “Datametrex is certainly among those companies. I am honoured to join the Board of this thriving Company; I look forward to further contribute to the strong innovative systems that make a difference in our society.”

The company has issued Jim 1,000,000 options.

As part of the Board changes, the Company announces that David Ellison is stepping down from the Board of Directors to make room for Jim, and will be joining the Advisory Board to continue supporting Datametrex with his legal expertise. Datametrex thanks David for his efforts and for still serving Datametrex to help solve the Company’s most pressing challenges.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email:  [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Else Nutrition $BABY.ca Completes Successful Toddler Nutrition U.S. Production Run and Opens Online Store for Pre-Orders $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:23 AM on Tuesday, July 28th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Announced that as part of its path to commercialization in the U.S., it has recently completed its first full-scale commercial production run of its Plant-based Toddler Nutrition product
  • The manufacturing run was successfully completed, meeting a rigorous set of quality standards
  • Additionally, the Company has launched pre-orders on its e-store (www.elsenutrition.com)
  • Customers in the U.S. and Canada can now place pre-orders, for delivery next month

VANCOUVER, BC / July 28, 2020 / Else Nutrition Holdings Inc. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company”), is pleased to announce that as part of its path to commercialization in the U.S., it has recently completed its first full-scale commercial production run of its Plant-based Toddler Nutrition product. The manufacturing run was successfully completed, meeting a rigorous set of quality standards. The production run was completed at the U.S. based facilities of the Company’s production partner, a leading producer of organic baby formula in the U.S.

Additionally, the Company has launched pre-orders on its e-store (www.elsenutrition.com). Customers in the U.S. and Canada can now place pre-orders, for delivery next month.

“These accomplishments further demonstrate our readiness for launch into the North American marketplace,” said Ms. Hamutal Yitzhak, CEO and Co-Founder of Else. “Parents across North America have been looking for clean, plant-based, whole food nutrition options for their children – and we are set to make this a reality.”

“Finding the right balance of healthy foods to promote optimal childhood growth and development can be a challenge for many parents. Else’s Plant-based toddler nutritional drink is clean nutrition , minimally-processed product, providing the appropriate vitamins and minerals content, plant-based proteins, and healthy fats and carbs . With so many available foods that are low in nutritional value, this product is a welcome addition to the market,” said Dr. Leah Alexander, Pediatrician, MD, FAAP.

Last month, Else began offering samples of its Plant-based Toddler Nutrition product on its site, receiving highly favorable customer reviews, “loving the clean, minimally processed ingredients” and welcoming a “healthier alternative.”

Customers in the U.S. and Canada can pre-order the full-sized Else Nutrition Plant-Based Complete Nutrition for Toddlers (in single and 4-pack offerings) on the Else e-store at: www.elsenutrition.com. A single 22 oz. product is available at the introductory price of USD$36, with a 4-pack priced at USD$136. Shipping in the Continental U.S. is free during the launch.

About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For additional information, contact:
Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: 604-603-7787

TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others Forward-looking statements made in this press release assume, among others, the timing of the Company’s toddler nutrition product launch and the availability of the Company’s product online. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Empower Clinics $CBDT.ca Reports Q1 2020 Results with 416% Revenue Increase $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:14 AM on Tuesday, July 28th, 2020
  • 5,717 patient visits generating total revenue of $789,135, compared to 1,198 patient visits generating $152,846 for Q1 2019

VANCOUVER, BC / July 28, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (OTCQB:EPWCF) (Frankfurt:8EC)(“Empower” or the “Company“) has filed today its unaudited interim condensed consolidated financial statements and related management’s discussion and analysis, both of which are available at www.SEDAR.com. All financial information in this press release is reported in United States dollars, unless otherwise indicated.

“Our strong Q1 2020 performance is a direct reflection of the numerous changes and improvements from 2019, setting in motion a framework for sustained growth.” said Steven McAuley, Chairman and CEO. “Our Sun Valley Health division started the year with record patient visits and now offers more diversified wellness services, adding new revenue sources and a more diversified business model.”

Q1 2020 Highlights

  • 5,717 patient visits generating total revenue of $789,135, compared to 1,198 patient visits generating $152,846 for Q1 2019.
  • Net loss of $524,208 or $0.00 per share, compared to $398,541 or $0.01 per share for Q1 2019, which was primarily driven by increased non-cash accretion expense.
  • Cash provided by operating activities was $13,864, compared to cash used by operating activities of $219,212 for Q1 2019.
  • Cash at March 31, 2020 of $131,808, compared to cash of $179,152 at December 31, 2019.

Recent Highlights Subsequent to Quarter End

  • Private Placement: Empower Clinics closes private placement of $653,000 CAD in April 2020 and $720,866 CAD in July 2020 to support growth initiatives.
  • Psychedelics Division: May 2020 Empower enters into a term sheet to acquire an interest in the global royalty rights of Dosed Movie, launches Dosed Wellness, a psychedelics brand, launches new dedicated website www.dosedwellness.com and adds new team members dedicated to the new brand.
  • COVID-19 Testing: April 2020 the Company launches a four-phase roll-out of COVID-19 testing in clinics and onsite for businesses.
  • Cannvas Education Platform: May 2020 Empower and EuroLife Brands complete definitive agreement for multi-year, multi-national licence of EurolIfe’s cannvas.me web-based education technology platform to deliver brand, product, and industry knowledge to the market.

Financial Summary

$, except where notedThree months ended March 31,
 20202019 
Patient visits (#)5,7171,198 
Clinic Revenues767,803152,846 
Direct Clinic Expenses256,42239,413 
Loss from operations(317,831)(279,308) 
Net loss(524,208)(398,541) 
Net loss per share(0.00)(0.01) 

Financial Performance

Clinic revenues for Q1 2020 and Q1 2019 were $767,803 and $152,846, respectively. This increase above prior year is attributable to the acquisition of Sun Valley and the addition of 5 clinics which drove an increase in patient count from 1,198 in Q1 2019 to 5,717 in Q1 2020.

Direct clinic expenses for Q1 2020 and Q1 2019 were $256,422 and $39,413, respectively. This increase above prior year is attributable to the increase in number of patient visits.

Net loss from operations for Q1 2020 and Q1 2019 were $317,831 and $279,308, respectively. This increase above prior year is primarily attributable to an increase in salaries and benefits with the acquisition of Sun Valley. This decrease was partially offset by an increase in clinic revenues with the acquisition of Sun Valley.

Net loss for Q1 2020 and Q1 2019 were $524,208 and $398,541, respectively. This increase over prior year is primarily attributable to non-cash accretion expense related to the convertible debentures.

During the three months ended March 31, 2020, the Company generated $13,864 in cash from operations after changes in non-cash working capital. The Company used $61,209 for payment of lease liabilities.

Please refer to the Company’s unaudited condensed interim consolidated financial statements for the three months ended March 31, 2020 and 2019, and accompanying Management Discussion and Analysis for a full review of the operations.

About Empower

Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options.

ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer

CONTACTS:

InvestorsDustin Klein Steven McAuley
 Director CEO
 720-352-1398 604-789-2146
 [email protected] [email protected]

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding the direction and growth prospects of the Company, the expansion of the company’s clinic and distribution network, the expected effect of the Vendors in their new roles with the Company, the effect on the lives of patients, the growth into a national brand, the effect of the Transaction, the diversification of the Company’s business model, the potential appeal to shareholders, the growth of the Company’s patient list and the effect thereof, the expected benefits for the company’s patient base and customers, the release of the cash consideration, the release of Shares being held in escrow in connection with the Transaction and statements regarding the Company’s proprietary product line “Sollievo”. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including that the Company may not be able to expand, that the Transaction may not have the expected results, and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

TransCanna’s $TCAN.ca First Commercial Batch of World Class Cannabis Concentrates in Collaboration with the Summit Boys Available in Stores This Week $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:11 AM on Tuesday, July 28th, 2020
tcan-square

  • First batch of its cannabis concentrate products that is being co-branded with award-winning product producer, the Summit Boys, will be available for purchase this week
  • Lyfted Farms Inc. (a TransCanna subsidiary) is now supplying high-quality-cannabis ‘trim’ (a by-product of cannabis flower production) to the Summit Boys for processing into an already popular line of cannabis concentrates branded as ‘Caviar’

Vancouver, British Columbia–(July 28, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) TransCanna announces that the first batch of its cannabis concentrate products that is being co-branded with award-winning product producer, the Summit Boys, will be available for purchase this week.

Lyfted Farms Inc. (a TransCanna subsidiary) is now supplying high-quality-cannabis ‘trim’ (a by-product of cannabis flower production) to the Summit Boys for processing into an already popular line of cannabis concentrates branded as ‘Caviar.’ These retail products now also include innovative packaging featuring a ‘window’ to showcase the superior color and texture of the concentrates.

Cannabis concentrates have a greater proportion of cannabinoids and terpenes when compared to natural cannabis flowers, and can increase the potency of cannabis flower. Demand for these concentrates are also the fastest-growing of any cannabis product in the California market (the largest Cannabis market globally.)

The Summit Boys are a well-known legacy recreational cannabis product producer with a cult-like following on Instagram of over 66,000 followers. In 2019, the Summit Boys earned over 14 Bay Area Cannabis Cup awards in several categories, including for Best Product and Hybrid Concentrate.

“The sale of these products is the first exciting step in our distribution plan to bring a higher-quality product to market by aligning with California’s most reputable industry partners, said Bob Blink, TransCanna CEO, adding that consumers recognize the Summit Boys for their quality of product and processing superiority. This collaboration also increases our profit margin for each harvest by converting trim, which can be valued as low as USD $0.15 per gram, into a refined finished product that wholesales for USD $17.00 per gram.”

“Our goal has always been to make the best tasting and smelling products that drive customers to come back for what we have to offer. Now that we are using even higher quality trim from Lyfted Farms we can’t wait to see how our customers react,” said Mike Larson, the Summit Boys CEO. “This is the best product that we’ve ever produced. Fire into the process equals fire out.”

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed Company building cannabis-focused brands for the California lifestyle through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board of Directors
Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs regarding future events of management of the Company. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements referred to herein as “forward-looking statements”, are not historical facts, are made as of the date of this news release and include without limitation estimates and forecasts and statements as to management’s expectations for growth and the commencement of operations of the Company’s Daly facility.

The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, including that operations will commence at the Company’s Daly facility in Modesto, California, as and when expected.

These forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially from any future results, events or developments expressed or implied by such forward-looking statements. Risks and uncertainties associated with the forward-looking information in this news release include, among others, dependence on obtaining and maintaining regulatory approvals, including state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete upgrades to its Daly facility in a timely manner; engaging in activities which currently are illegal under U.S. federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; reliance on management; and the effect of capital market conditions and other factors (including those related to the COVID-19 pandemic) on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look, except in accordance with applicable securities laws.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN

“I believe #AR could be bigger than the web,” said Scott Belsky, chief product officer of #Adobe Creative Cloud $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 12:58 PM on Monday, July 27th, 2020

SPONSOR: Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality platform that allows businesses to easily launch AR campaigns. Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape and The Basketball Hall of Fame. The company recently announced partnership with Engaged Nation, an award winning leader in digital engagement marketing for casinos in addition to a collaboration with Music Superstar Flo Rida Learn More.

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

“I believe AR could be bigger than the web,” said Scott Belsky, chief product officer of Adobe Creative Cloud. “But we have to unlock artists’ full potential in this new medium. And we need rules and standards for where, when, and how AR appears. It can be a lifesaver, but it can also be dangerously distracting. We’ll find the boundaries through responsible exploration.”

by CMO.com Team

This bridges the physical and digital worlds, opening up a new realm for creators and marketers to explore and experiment. Add to that the ongoing proliferation of voice interfaces, and it is clear to see that consumers are demanding more experiences that provide information in clever ways and stir emotions. Voice and immersive media can seamlessly permeate the environment around us and fulfill that demand with fresh, personal, and meaningful experiences.

“We think AR, combined with AI, can be a killer combination of experiences unlike anything we’ve seen before,” said Abhay Parasnis, EVP and CTO at Adobe.

AR promises retail environments where people can interact digitally with physical objects. For example, companies are already experimenting with using AR to give consumers X-ray vision to see internal construction or details of products, such as size and colors available in stock. AR also promises to impact the future of work, with more remote meetings in which on-site staff can collaborate creatively with virtual colleagues, as if they were working in the same room.

However, to realize the full promise of AR, the tools that let artists express their creative vision must evolve as well. Spatial design requires moving beyond current physical and digital tools to a multisensory approach that uses natural inputs, like voice, sight, touch, and gestures. As the means become more intuitive, the mechanics will fade into the background. Then, artists, designers — everyone — can explore the new dimension and craft experiences that know no limits.

Enabling AR With AI
For designers, the mental shift from 2D to 3D — and spatial design — requires new tools and skills to work and thrive in a different dimension. AI is enabling the shift to more realistic and engaging experiences and more powerful personalization.

Creating AR experiences that look and feel convincing calls for rendering, lighting, materials, and objects that behave according to real-world rules. Using AI and machine learning, 3D design tools can handle time-consuming tasks and create photorealistic results that previously required costly photo shoots or hours of creative work.

“AI is enabling creators to develop immersive experiences much faster and with greater fidelity than ever before, and promises to empower individuals to interact with those experiences in real time,” said Tatiana Mejia, product marketing and strategy at Adobe.

Indeed, AI provides invaluable capabilities beyond accelerating content creation. For example, personalizing experiences and providing contextually relevant information in real time requires prodigious processing power. Learning from users’ reactions and predicting what they’ll want next demands instantaneous decision-making. This is where AI shines. AI can help designers use data on customer preferences to show products in 3D instantly, with favorite logos, colors, and sizes.

On the flip side, AI and machine learning can help experience businesses learn from every customer interaction so they continually become better at delivering the right offer. And using computer vision and neural networks, AR can lower barriers to online purchases, letting customers virtually try on clothes and experiment with make-up colors.

AI-powered tools for spatial design will make it easier to bring stories to life around us. Creatives working on the forefront of AR are already offering a hint of the limitless possibilities.

Bridging The Physical And Digital Worlds
“We’re used to art that lives in the physical world,” said Stefano Corazza, head of augmented reality at Adobe. “And we’re familiar with interactive experiences that live on a screen. AR is bridging these two worlds. It’s providing new flexibility and fluidity to the physical world.”

With AI-powered AR, object recognition and tracking, gestural input, eye tracking, and voice commands can combine to let users engage with 2D and 3D objects in virtual space with hands, eyes, and words. Visual artists gain a new medium for expression, brands and consumers gain a new way to interact, and colleagues gain a new way to communicate.

While many of the applications of AR have yet to be discovered, below we look at four ways artists, designers, and brands are using AR to make experiences more expressive, informative, interactive, and collaborative.

Example 1: Animation Anywhere
AR can transform everyday experiences into the extraordinary. And for some, AR provides a new way to express feelings that can’t be captured in any other way.

Artists Zach Lieberman and Molmol Kuo incorporated multisensory design capabilities in the iOS AR app Weird Type, which lets users write and animate anything, anywhere, in 3D space. That led to people using the app to tell a story about location, build sculptures, and describe sensations difficult to put into words, like the feeling of the wind.

With AR, companies can connect to customers through all of their senses. Combining 2D and 3D in AR can also help sell a vision, such as a new product design, to stakeholders and clients. Designers and developers can work together to build engaging experiences that marketers distribute via a brand’s app. And in addition to retail, AR offers endless opportunities in other realms, including medical training, tourism, advertising, and entertainment.

Example 2: Augmented Retail Experiences
A demonstration at the 2019 Adobe EMEA Summit, as reported by CNBC, showed how customers in a Foot Locker store could rotate and “explode” an AR shoe to learn about its construction, see a model in various colors, virtually discard rejected options, and check the stock for shoes in the appropriate size. All the information a customer could want appears as if by magic with the power of AI — and without ever asking a clerk for help.

Example 3: Immersive Art
A recent San Francisco Museum of Modern Art exhibit featured interactive artwork inspired by René Magritte. As reported by NVIDIA, visitors could insert themselves in paintings via an AR experience, mixing their images with the art. The relationship between creator and audience transforms, as AR allows consumers to “add” to a design. Interacting with Magritte’s work created a strong connection between visitors and the art, deepening their appreciation of it.

Example 4: Close Collaboration From Afar
Spatial computing lets colleagues collaborate from anywhere in AR, making them more productive and creative — and helping everyone feel more connected. Users can share their reality with transported 3D copies of colleagues, point at objects of interest, and write on virtual post-it notes they can even stick on the wall.

“AR challenges us to design for human perception, not pixels, when we integrate sight, speech, movement, haptics, and context,” said Silka Miesnieks, head of emerging design at Adobe.

Overcoming The Boundaries
In the era of AR and AI, artists and designers, marketers and developers — and eventually everyone — will make the shift to the multidimensional, multisensory, immersive world. We must rethink design principles, the creator’s role, and reimagine experiences to center on what humans, not devices, can do and with deep understanding of what moves them.

As immersive technologies transform creativity, creative tools should set designers free to work and play in new worlds and to think in disruptive new ways, no longer constrained by the boundaries of the past. AI can help speed creation and personalize the experiences. But for mass adoption, creative tools must become more intuitive and contextually appropriate.

With further advances in machine learning, the tools professionals already know will become more intuitive, assisting humans to explore spatial design with more integrated, seamless workflows. Voice recognition using natural language commands can simplify user interfaces and streamline processes.

Spatial computing promises solutions to previously unsolved problems, such as better city planning to address climate change, medical breakthroughs, and education that caters to a greater diversity of abilities using our sense of spatial memory through AR. It will challenge designers to create more immersive experiences while being transparent about how experiences are created, enhanced, and delivered. 

“I believe AR could be bigger than the web,” said Scott Belsky, chief product officer of Adobe Creative Cloud. “But we have to unlock artists’ full potential in this new medium. And we need rules and standards for where, when, and how AR appears. It can be a lifesaver, but it can also be dangerously distracting. We’ll find the boundaries through responsible exploration.”

Source: https://cmo.adobe.com/articles/2019/8/how-aipowered-augmented-reality-transforms-digital-experiences.html#gs.baxqr7

Datametrex $DM.ca Announces Sale of COVID-19 Test Kits to Canadian Mining Company TMAC Resources $TMR.ca

Posted by AGORACOM-JC at 11:39 AM on Monday, July 27th, 2020
  • Received a purchase order (the “PO”) for COVID-19 test kits and services from Canadian based mining company TMAC Resources Inc. (the “Purchaser”) with operations in Nunavut, Canada
  • The initial pilot PO is approximately $200,000

TORONTO, July 27, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has received a purchase order (the “PO”) for COVID-19 test kits and services from Canadian based mining company TMAC Resources Inc. (the “Purchaser”) with operations in Nunavut, Canada. The initial pilot PO is approximately $200,000.

The Company has secured all requested test kits, swabs, tubes, PPE and the lab time. All of the items will be delivered directly to the mining company at their muster site in Edmonton, Alberta.. Testing services are conducted by Transpharm Canada Inc. (“TCI”). The Company does not anticipate any costs associated with the sale of these kits.

“Datametrex is pleased in assisting TMAC with implementing testing for response to COVID-19, and keeping its employees, the community in Nunavut safe.” says Marshall Gunter, CEO of the Company. “The thinking is simple; an individual who tests positive before arriving in Nunavut can be isolated until they recover, effectively negating the rate of transmission in the community.”

Under the terms of the PO, Datametrex will deliver to the purchaser an initial 2,000 units of the Health Canada authorized COVID-19 qPCR Detection Kits manufactured by 1drop Inc., and 3 mL Univesal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes. The testing is being conducted by Dr. Alexander MacGregor and his team from Transpharm Canada Inc. (“TCI”) at the TMAC’s muster point.

TMAC stated that they are focused on ensuring the health, safety and well-being of local communities, all employees, contractors, and visitors, including;

  • providing safety training and education to ensure a capable and resilient work force;
  • promoting healthy work practices, work organization and a culture of health and wellbeing in the workplace and in local and Inuit communities;
  • participating in emergency response training to protect the health and safety of the work force, visitors and local and Inuit communities; and
  • maintaining occupational health programs and emergency preparedness.

About TMAC

TMAC Resources Inc. is a Canadian-based mining company which holds a 100% interest in the Hope Bay Property. Its vision and sole focus is the responsible and economically sustainable exploration, development and mining of the Hope Bay greenstone belt, an eighty kilometre by twenty kilometre property with significant upside resource potential in the Kitikmeot region of Nunavut as Canada’s next major gold mining camp. TMAC is a gold producer with the Doris mine achieving commercial production in 2017 and the Madrid and Boston deposits expected to commence production in 2020 and 2022, respectively. TMAC has an experienced and expert board of directors and exploration, development and operating teams with extensive track records of discovering, developing and operating high grade, profitable underground mines. TMAC’s shares trade on the Toronto Stock Exchange under the trading symbol TMR.

Additional information on TMAC is available at www.tmacresources.com

About 1drop Inc.

1drop Inc. aims to provide a solution to manage health with a drop of fluid. It has the key technologies for becoming a global leading company in the field of smart health care. 1copy™ COVID-19 qPCR Multi Kit can reduce the risk of asymptomatic and latent infection of COVID-19 by a single virus level limit of detection. Additional information on 1drop Inc. is available at www.1drop.co.kr

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.